<DOC>
	<DOCNO>NCT02858219</DOCNO>
	<brief_summary>The main objective study compare efficacy botulinum toxin injection vestibulodynia pain compare group treat placebo .</brief_summary>
	<brief_title>A Pilot Study Effects Botulinum Toxin Treatment Provoked Vestibulodynia</brief_title>
	<detailed_description />
	<mesh_term>Vulvodynia</mesh_term>
	<mesh_term>Vulvar Vestibulitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subject refractory conventional treatment ( tricyclic antidepressant benzodiazepine analgesic dos , biofeedback physical therapy ) Negative screen test result Notified associate factor Menopause , surgically sterilize woman woman use effective contraceptive method Good understanding predictable adherence protocol beneficiary/affiliated French social security/social healthcare sign Informed Consent Form Predictable poor adherence Pregnant breastfeed woman Myasthenia Treatment aminoglycosides Major mental disorder Underlying etiology Vulnerable subject ( particularly adults guardianship ) Any reason deem relevant investigator Current former ( last 3 month ) participation another clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Botulinum toxin</keyword>
	<keyword>Pain improvement</keyword>
</DOC>